ADVANCED ENZYME TECHNOLOGIES
Back to Balance Sheet
|
ADVANCED ENZYME TECHNOLOGIES Last 5 Year Total Non-Current Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Non-Current Liabilities | ₹44 Cr | ₹49 Cr | ₹59 Cr | ₹49 Cr | ₹39 Cr |
What is the latest Total Non-Current Liabilities ratio of ADVANCED ENZYME TECHNOLOGIES ?
Year | Total Non-Current Liabilities |
---|---|
Mar2024 | ₹44 Cr |
Mar2023 | ₹49 Cr |
Mar2022 | ₹59 Cr |
Mar2021 | ₹49 Cr |
Mar2020 | ₹39 Cr |
How is Total Non-Current Liabilities of ADVANCED ENZYME TECHNOLOGIES Trending?
Years | Total Non-Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹44 Cr | -10.30 | |
Mar2023 | ₹49 Cr | -17.87 | |
Mar2022 | ₹59 Cr | 20.87 | |
Mar2021 | ₹49 Cr | 26.91 | |
Mar2020 | ₹39 Cr | - |
Compare Total Non-Current Liabilities of peers of ADVANCED ENZYME TECHNOLOGIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
ADVANCED ENZYME TECHNOLOGIES | ₹3,751.4 Cr | -2.9% | -11.9% | -7.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹418,936.0 Cr | -5.8% | -3.2% | 35.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹152,157.0 Cr | -2.8% | -3.6% | 44.7% | Stock Analytics | |
CIPLA | ₹116,200.0 Cr | -3.9% | -0.5% | 13.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹111,325.0 Cr | -1.2% | 7.1% | 17.8% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹98,037.4 Cr | -2.7% | -0.1% | 40.9% | Stock Analytics |
ADVANCED ENZYME TECHNOLOGIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
ADVANCED ENZYME TECHNOLOGIES | -2.9% |
-11.9% |
-7.4% |
SENSEX | -2.1% |
-6.4% |
7% |
You may also like the below Video Courses